The drug Prevnar is a vaccine meant to prevent certain types of bacterial meningitis. It is typically administered to infants starting around 2 months of age. In randomized, double-blind clinical trials of Prevnar, infants were randomly divided into two groups. Subjects in group 1 received Prevnar, while subjects in group 2 received a control vaccine. After the second dose, 137 of 452 subjects in the experimental group (group 1) experienced drowsiness as a side effect. After the second dose, 31 of 99 subjects in the control group (group 2) experienced drowsiness as a side effect. Does the evidence suggest that a lower proportion of subjects in group 1 experienced drowsiness as a side effect than subjects in group 2 at the α = 0.05 level of signiﬁcance?
Answer to relevant QuestionsIn October 1947, the Gallup organization surveyed 1100 adult Americans and asked, “Are you a total abstainer from, or do you on occasion consume, alcoholic beverages?” Of the 1100 adults surveyed, 407 indicated that they ...In clinical trials for treatment of a skin disorder, 642 of 2105 patients receiving the current standard treatment were cured of the disorder and 697 of 2115 patients receiving a new proposed treatment were cured of the ...In a survey of 3029 adult Americans, the Harris Poll asked people whether they smoked cigarettes and whether they always wear a seat belt in a car. The table shows the results of the survey. For each activity, we deﬁne a ...On April 12, 1955, Dr. Jonas Salk released the results of clinical trials for his vaccine to prevent polio. In these clinical trials, 400,000 children were randomly divided in two groups. The subjects in group 1 (the ...To test the belief that sons are taller than their fathers, a student randomly selects 13 fathers who have adult male children. She records the height of both he father and son in inches and obtains the following data. Are ...
Post your question